Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Completed · Phase 3 · Has a placebo group
Conditions studied: Gastric Adenocarcinoma
In brief
The primary objective of this study is to compare the efficacy of andecaliximab (GS-5745) versus placebo in combination with modified fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (OXA) (mFOLFOX6) as measured by overall survival.
Key facts
- Study ID
- NCT02545504
- Run by
- Gilead Sciences
- People needed
- 432
- Starts
- 2015-10-13
- Expected to finish
- 2019-05-15
- Last updated by the study team
- 2020-05-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Southern California — Los Angeles, California, United States
- UCLA Jonsson Comprehensive Cancer Center — Los Angeles, California, United States
- Innovative Clinical Research Institute — Whittier, California, United States
- Cancer Center of Central Connecticut — Plainville, Connecticut, United States
- Omega Research Consultants LLC — DeBary, Florida, United States
- Edward Hospital & Health Services — Naperville, Illinois, United States
- Parkview Hospital — Fort Wayne, Indiana, United States
- Indiana University Goshen Center for Cancer Care — Goshen, Indiana, United States
- Ochsner Clinic Foundation — New Orleans, Louisiana, United States
- New England Cancer Specialists — Scarborough, Maine, United States
- Karamanos Cancer Institute — Detroit, Michigan, United States
- HCA Healthcare — Kansas City, Missouri, United States
- Carol G. Simon Cancer Center — Morristown, New Jersey, United States
- Regional Cancer Care Associates LLC - Sparta — Sparta, New Jersey, United States
- Weill Cornell Medical College - New York Presbyterian Hospital — New York, New York, United States
- University of Rochester — Rochester, New York, United States
- Duke Cancer Institute — Durham, North Carolina, United States
- Oncology Hematology Care, Inc. — Cincinnati, Ohio, United States
- The Ohio State Medical Center — Columbus, Ohio, United States
- Northwest Cancer Specialists — Portland, Oregon, United States
- Charleston Hematology Oncology Associates — Charleston, South Carolina, United States
- Prairie Lakes Health Care System INC — Watertown, South Dakota, United States
- Tennessee Oncology — Nashville, Tennessee, United States
- Center for Cancer Blood Disorders — Fort Worth, Texas, United States
- Scripps Green Hospital — La Jolla, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.